Cargando…
A251 NON-ALCOHOLIC FATTY LIVER DISEASE AT A CANADIAN TERTIARY CARE CENTRE: RISK FACTORS AND SEVERITY OF DISEASE
BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is the leading cause of liver disease worldwide with an increasing prevalence of 25-40%. Although the prevalence increases to 57.5-74% in obese patients, lean individuals also develop NAFLD. Patients are commonly asymptomatic and the diagnosis is...
Autores principales: | Klemm, N K, Zhu, K, Jaffer, A, Ramji, A, Mohajerani, A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9991119/ http://dx.doi.org/10.1093/jcag/gwac036.251 |
Ejemplares similares
-
Metabolism of cyclic GMP in non-alcoholic fatty liver disease in morbid obesity
por: Urios, Amparo, et al.
Publicado: (2011) -
A245 A TERTIARY CENTRE REVIEW OF PORTO-SYSTEMIC SHUNTS: AN INCREASINGLY IMPORTANT TOOL IN LIVER DISEASE MANAGEMENT
por: Malik, S, et al.
Publicado: (2023) -
P251: Prospective survey of the practice of curative antibiotic treatment in an infectious diseases department in Dakar
por: Dia, NM, et al.
Publicado: (2013) -
A126 ASSESSING THE QUALITY OF REFERRALS AND ADJUDICATION FOR ENDOSCOPIC RESECTION OF LARGE COLORECTAL POLYPS AT A CANADIAN TERTIARY REFERRAL CENTRE
por: Xiao, Y, et al.
Publicado: (2023) -
A286 THE ROLE OF A GUT HORMONE VERSUS NUCLEAR FACTOR-KAPPA B IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE
por: Abdel-Samiee, M, et al.
Publicado: (2023)